Actively Recruiting
Wheat Beer for Prevention of Delirium in Intensive Care Patients
Led by University Hospital, Basel, Switzerland · Updated on 2025-02-11
380
Participants Needed
1
Research Sites
362 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators hypothesise that the daily administration of 0.5L alcohol-containing wheat beer at 8 pm over a study period of 6 days in a row leads to a lower prevalence of delirium compared to water following the same administration scheme.
CONDITIONS
Official Title
Wheat Beer for Prevention of Delirium in Intensive Care Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ICU patients expected to stay at least 24 hours
- Naso-gastric tube in place
- ICU stay of 72 hours or less before first study treatment
- Women must have a negative pregnancy test, be 50 years or older, or have had hysterectomy/bilateral ovariectomy
- Adults aged 18 years or older
- Body weight at least 50 kg or BMI of at least 18.5
You will not qualify if you...
- Existing liver disease
- Patients after bone marrow transplantation
- Women who are breastfeeding
- Existing delirium with ICDSC score 4 or higher
- Terminal illness
- Active psychosis
- History of complete alcohol abstinence or alcohol abuse
- Especially vulnerable patients
- Allergy to any ingredient in beer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here